IP23-19: Impact of Prior Chemotherapy on Survival and Safety Outcomes of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

IP23-19: Impact of Prior Chemotherapy on Survival and Safety Outcomes of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!